2seventy bio, Inc.
NASDAQ:TSVT
Overview | Financials
Company Name | 2seventy bio, Inc. |
Symbol | TSVT |
Currency | USD |
Price | 4.4 |
Market Cap | 226,590,892 |
Dividend Yield | 0% |
52-week-range | 1.535 - 6.4 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Nick Leschly |
Website | https://www.2seventybio.com |
An error occurred while fetching data.
About 2seventy bio, Inc.
2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. Its products pipeline includes idecabtagene vicleucel; ide-cel or Abecma and bb21217; and CAR-T cell product candidates for the treatment of multiple myeloma. 2seventy bio, Inc. has
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD